 |

Dr. Kevin Kjernisted
| |
VAN AMERINGEN M., MANCINI, C., OAKMAN, J., WALKER, J., KJERNISTED, K., CHOKKA, P., JOHNSTON, D., BENNETT, M., PATTERSON, B., (2007). Nefazodone in the Treatment of Generalized Social Phobia: A Randomized, Placebo-controlled Trial. Journal of Clinical Psychiatry, 68(2):188-95.
|
|
| |
SAREEN, J., CAMPBELL, D.W.; LESLIE, W.D., MALISZA, K.L., STEIN, M.B., PAULUS, M.P., KRAVETSKY, L.B., KJERNISTED, K.D., WALKER, J.R., REISS, J.P., (2007). Striatal Function in Generalized Social Phobia: A Functional Magnetic Resonance Imaging Study. Biol Psychiatry, 61(3):396-404.
|
|
| |
FOA, E.B., Liebowitz, M.R., Kozak, M.J., Davies, S., Campeas, R., Franklin, M.E., Huppert, J.D., Kjernisted, K., Rowan, V., Schmidt, A. B., Simpson, H.B., Tu, X., (2005). Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive Compulsive Disorder. American Journal of Psychiatry, 162(1):151-161.
|
|
| |
SAREEN, J., Kirshner, A. Lander, M., Kjernisted, KD., Eleff, MK., Reiss, JP., (2004). Do Antipsychotics Ameliorate or Exacerbate Obsessive Compulsive Disorder Symptoms? A Systematic Review. Journal of Affective Disorders, 82(2):167-174.
|
|
| |
TORGRUD, L.J., Walker, J.R., Murray, L., Cox, B.J., Chartier, M., Kjernisted, K.D., (2004). Deficits in perceived social support associated with generalized social phobia. Cognitive Behaviour Therapy, 33(2):87-96.
|
|
| |
SIMPSON, H.B., Liebowitz, M.R., Foa, E.B., Kozak, M.J., Schmidt, A.B., Rowan, V., Petkova, E., Kjernisted, K., Huppert, J.D., Franklin, M.E., Davies, S.O., Campeas, R. , (2004). Post-Treatment Effects of Exposure Therapy and Clomipramine in Obsessive-Compulsive Disorder. Depression and Anxiety, 19(4): 225-233.
|
|
| |
KJERNISTED, K.D., Bleau, P., (2004). Long-Term Goals in the Management of Acute and Chronic Anxiety Disorders. Canadian Journal of Psychiatry, 49 (3 Suppl 1):51S-63S.
|
|
| |
KJERNISTED, KD., ENNS, M.W., LANDER, M. (2002). An Open-Label Clinical Trial of Nefazodone in Hypochondriasis, Psychosomatics 43, (4):290-294.
|
|
| |
SAREEN, J., CHARTIER, M., KJERNISTED, KD., STEIN, M.B., (2001).
Comorbidity
of Phobic Disorders With Alcoholism in a Canadian Community Sample. Canadian Journal of Psychiatry, 46(8): 733-740.
|
|
| |
COX, B.J., ENNS, M.W., WALKER, J.R., KJERNISTED, K.D., PIDLUBNY, S.R., (2001). Psychological Vulnerabilities in Patients with Major Depression versus Panic Disorder. Behaviour Research and Therapy, 39(5):567-573.
|
|
| |
WALKER, J.R., KJERNISTED, K.D. (2000) Fear: The Impact and Treatment of Social Phobia. Journal of Psychopharmacology, 14 (2) (Supplement 1); S13-S23.
|
|
| |
WALKER, J.R., VINCENT, N., FURER, P., COX, B.J., KJERNISTED, K.D. (1999) Treatment Preference in Hypochondriasis. Journal of Behaviour Therapy and Experimental Psychiatry, 30(4), 251-258.
|
|
| |
KATZ, L., FLEISHER, W., KJERNISTED, K.D., MILANESE, P., (1996). A Review of the Psychobiology and Pharmacotherapy of PTSD. Canadian Journal of Psychiatry, 41(4):233-238.
|
|
« Back to Research |
|
|
|